The Life Sciences Marketing Agency

A life sciences marketing agency specializes in helping companies in that sector (including biotech tools, lab instruments, CROs, and scientific services) reach and convert their target buyers. Unlike generalist agencies, a life sciences marketing agency understands the technical nature of scientific products, the decision-making process of researcher and clinical buyers, and the content formats that earn credibility with those audiences.

Life sciences marketing means selling to highly technical buyers who evaluate vendors with exceptional rigor, including scientists, researchers, lab directors, and clinical professionals. Generic claims are immediately recognized and dismissed. Effective life sciences marketing requires demonstrating genuine understanding of the specific problem a buyer is solving, using precise language that reflects the science, and building content that earns credibility before it asks for a conversion.

Three Seven works with established life sciences companies that sell technical products or services to scientific and clinical buyers, often operating under strict technical and regulatory standards — including life science instrument companies, assay and reagent manufacturers, contract research organizations (CROs), biotech tools and platform companies, and scientific software providers. We focus on B2B commercial marketing for companies selling to researchers and scientific professionals, not on pharmaceutical advertising or clinical content.

Three Seven provides marketing strategy, web design and development, brand identity and messaging, digital marketing (SEO, paid search, content, email, social), and CRM workflow. All disciplines are handled by the same team as one integrated system without handoffs between strategy and execution.

Buyer understanding is the most important factor. A strong life sciences marketing agency knows that researchers and clinical professionals evaluate vendor with an extremely high bar for credibility. Look for agencies with experience in your buyer segment, demonstrated knowledge of how scientific purchasing decisions are made, and a strategy-first approach rather than a deliverable-first one. Month-to-month contract terms with a clear exit option are also worth requiring, as they signal the agency believes in its own work.

Timeline depends on the channel. Paid search can generate leads within the first few days or weeks once campaigns are optimized. SEO/AI and content build over 3–6 months as pages index and gain authority. Brand and messaging work affects conversion rates and pipeline quality on an ongoing basis as your positioning lands with the right buyers. The fastest results consistently come when the strategy is right before execution begins, which is why we start every engagement with a diagnostic phase.

No. Three Seven doesn’t handle patient-facing pharmaceutical advertising, FDA regulatory communications, or clinical content writing. Our focus is B2B commercial marketing for life sciences companies selling products and services to researchers, lab professionals, and clinical teams — not to patients. If you’re a CRO, instrument company, reagent manufacturer, or biotech tools company, we’re likely a fit. If you need medical affairs content or DTC pharma campaigns, we’re not the right agency.

Retainers for life sciences engagements start at $2,500 per month and scale with scope, with ad spend passed through at cost and never marked up. Website projects run $20,000 to $100,000 depending on complexity and how much strategy the build requires. Every retainer begins with a paid strategy and action plan phase. If you don’t approve the strategy at the end of it, we refund your deposit.

Both, and the distinction is worth understanding before you hire anyone. Our specialization is the buyer type: expert-to-expert B2B, where the person evaluating you knows more about the subject than most marketers ever will. Life sciences is one of the places that buyer concentrates, alongside industrial manufacturing, engineering, and scientific software. We’ve worked in life sciences and medical since 2010, with assay manufacturers, genomics and proteomics companies, clinical laboratories, and research organizations. The practical effect is that we understand how a scientific buyer evaluates before we understand your specific product.

Every engagement starts with a paid strategy and action plan phase, before any retainer or build begins. We run discovery on what’s been tried and where pipeline actually comes from today, diagnose what’s broken — often upstream of the thing you came in for — and deliver a written recommendation your team can defend internally. Then we pressure-test it with you. If you don’t approve it, we refund your deposit. Some engagements end there by design, with the recommendation executed in-house.

Against pipeline, not activity. Traffic and impressions tell you a campaign ran. They don’t tell you whether it produced qualified opportunities. We build attribution and reporting into the engagement rather than delivering it as an afterthought, so you can trace inbound leads back to source and defend the number in a budget review. For long scientific sales cycles this matters more than usual, because the lag between a first visit and a purchase order can run several quarters.

Yes, and it’s increasingly where scientific buyers start. We publish original research on how AI systems decide which brands to cite, based on 27 studies and 20 million AI citations across seven platforms. The short version: quantified, sourced, specific content gets cited, and vague positioning language does not. We apply the same standard to client sites that we apply to our own.